-
Israeli researchers develop AI tool that deciphers herpesviruses activation
05 Feb 2026 17:25 GMT
… on the lips (oral herpes), or diseases such as … ;ll be able to develop medications and tools for early detection … of cancer."
Beyond herpes
The detection and identification … will focus on treatment with drugs and preventive treatments of diseases caused …
-
Aicuris Presents Positive Phase 3 Data for Pritelivir in Immunocompromised Patients with Refractory Herpes Simplex Virus at TANDEM
05 Feb 2026 10:00 GMT
… trial (PRIOH-1, NCT03073967), evaluating pritelivir in immunocompromised patients with refractory herpes … with fewer drug-related treatment-emergent adverse … helicase-primase inhibitor developed by Aicuris, … therapies to effectively treat infection. Our …
-
MPNFS Framework for Managing Herpes Zoster and Refractory Pain in an Immunotherapy-Treated Lung Cancer Patient: A Case Report
04 Feb 2026 12:49 GMT
… ; HZ, herpes zoster; IDDS, intrathecal drug delivery system … to address through pharmacologic treatment alone. The MPNFS … cancer, this case developed herpes zoster, and serous … treatment phase, which exacerbated anxiety. The pain team strengthened medication …
-
Innovative Herpes Simplex Virus Therapy Candidate Presents Phase 3 Data
04 Feb 2026 05:38 GMT
… Drug Administration (FDA) has not yet approved any vaccine for the herpes … antiviral medications can help shorten the duration of herpes outbreaks. … limited treatment options.
The PRIOH-1 trial focused … website here.
This development highlights progress in …
-
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Adults and Adolescents With Vitiligo
04 Feb 2026 00:59 GMT
… medication available for patients with vitiligo, addressing important treatment … at higher risk of developing shingles (herpes zoster). Increased risk … ask your HCP or pharmacist.
What should I avoid … of prescription drugs to the FDA. Visit www.fda.gov…
-
Antiviral Drugs Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033
03 Feb 2026 10:29 GMT
… report:
◘ By Drug Class: DNA Polymerase Inhibitors … Herpes, Influenza, and Others
◘ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies … processes and product development.
➤ Antiviral Drugs Research Methodology:
…
-
Real-World Comparability of Antiresorptive Osteoporosis Treatment Groups Among Treatment-Naïve and Treatment-Experienced Women Ages 55 and Older in the United States
02 Feb 2026 13:58 GMT
… Consensus Development Panel … Pharmacoepidemiol Drug Saf. 2020 … drugs/news-events-human-drugs/fda-approves-first-interchangeable-biosimilars-prolia-and-xgeva-treat … treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med …
-
GARM Clinic Introduces HSV Immunotherapy Protocol to Help Patients Break the Cycle of Recurrent Outbreaks
05 Feb 2026 14:00 GMT
Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management
ROATAN, BAY ISLANDS, HONDURAS, February 5, 2026 /EINPresswire.com/ -- GARM Clinic, a specialized medical facility focused on advanced …
-
<![CDATA[Navigating the Evolving COPD Care Landscape: A Call for Proactive Biologic Intervention]]>
02 Feb 2026 22:16 GMT
… to implementing personalized treatment strategies, particularly for … .
Opportunistic Infections: Herpes Zoster
Herpes zoster infections have … (Helminth) Infection
Treat patients with pre-existing … ;copd/treating/copd-medications Accessed December 11 …
-
<![CDATA[Upadacitinib Safe for Atopic Dermatitis up to 7 Years in Pooled Analysis Findings]]>
02 Feb 2026 22:16 GMT
Long-term use of upadacitinib (UPA) over 7 years among patients with moderate-to-severe atopic dermatitis is safe, new data suggest.1
This conclusion regarding UPA’s safety in atopic dermatitis was the result of a recent pooled analysis presented at the …